US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carlsmed, Inc.

12.97

-0.3600-2.70%

Post-market: 13.000.0300+0.23%19:52 EDT

Volume:133.15K

Turnover:1.75M

Market Cap:344.76M

PE:-2.12

High:13.46

Open:13.40

Low:12.81

Close:13.33

52wk High:16.20

52wk Low:11.81

Shares:26.58M

Float Shares:6.70M

Volume Ratio:1.71

T/O Rate:1.99%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.1272

EPS(LYR):-6.1108

ROE:--

ROA:--

PB:-4.15

PE(LYR):-2.12

Loading ...

Overview Company News Filings

Carlsmed appoints Jennifer Kamocsay as CLO, secretary

Carlsmed Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary Amid Leadership Expansion

Carlsmed Inc. Joins Russell 2000® Index

Goldman Sachs Highlights Two High-Potential Stocks: AI Marketing Platform Braze (BRZE.US) and Medical Technology Carlsmed (CARL.US) Receive "Buy" Ratings

BRIEF-Carlsmed® Reports Second Quarter 2025 Financial Results

Carlsmed Q2 Loss Narrows, Revenue Rises

MT Newswires Live

Carlsmed Q2 EPS $(1.47) Misses $(1.15) Estimate, Sales $12.083M Beat $11.984M Estimate

Carlsmed Inc - Reports Q2 Revenue of $12.1 Mln

THOMSON REUTERS

Carlsmed Inc - Full Year Revenue Guidance $45.5M - $47.5M

THOMSON REUTERS

Press Release: Carlsmed(R) Reports Second Quarter 2025 Financial Results

Calendar of U.S. Earnings Expected in the Week Ahead

Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage

Benzinga_recent_news

Carlsmed Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $16

THOMSON REUTERS

BTIG Research Initiates Coverage on Carlsmed With Buy Rating, $21 Price Target

MT Newswires Live

Carlsmed Inc : Truist Securities Initiates Coverage With Buy Rating; Price Target $18

THOMSON REUTERS

Carlsmed Inc : Btig Initiates Coverage With Buy Rating; Target Price $21

THOMSON REUTERS

Carlsmed Initiated at Overweight by Piper Sandler

Truist Initiates Carlsmed at Buy With $18 Price Target

MT Newswires Live

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CARL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CARL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CARL\",,,,,undefined,":{"symbol":"CARL","market":"US","secType":"STK","nameCN":"Carlsmed, Inc.","latestPrice":12.97,"timestamp":1759521600000,"preClose":13.33,"halted":0,"volume":133147,"hourTrading":{"tag":"盘后","latestPrice":13,"preClose":12.97,"latestTime":"19:52 EDT","volume":17918,"amount":236990.06,"timestamp":1759535531092},"delay":0,"floatShares":6700000,"shares":26581134,"eps":-6.127181,"marketStatus":"Market Closed","change":-0.36,"latestTime":"10-03 16:00:00 EDT","open":13.4,"high":13.4563,"low":12.81,"amount":1749760.76948,"amplitude":0.048485,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.127181,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1759737600000},"marketStatusCode":7,"adr":0,"listingDate":1753243200000,"exchange":"NASDAQ","adjPreClose":13.33,"preHourTrading":{"tag":"盘前","latestPrice":13.33,"preClose":13.33,"latestTime":"08:51 EDT","volume":33000,"amount":439890,"timestamp":1759495860709},"postHourTrading":{"tag":"盘后","latestPrice":13,"preClose":12.97,"latestTime":"19:52 EDT","volume":17918,"amount":236990.06,"timestamp":1759535531092},"volumeRatio":1.7116645441616116},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CARL\",,,,,undefined,":{"symbol":"CARL","floatShares":6700000,"roa":"--","roe":"--","lyrEps":-6.110816,"volumeRatio":1.7116645441616116,"shares":26581134,"dividePrice":0,"high":13.4563,"amplitude":0.048485,"preClose":13.33,"low":12.81,"week52Low":11.81,"pbRate":"-4.15","psRate":"9.01","week52High":16.2,"institutionHeld":0,"latestPrice":12.97,"eps":-6.127181,"divideRate":0,"volume":133147,"delay":0,"ttmEps":-6.127181,"open":13.4,"prevYearClose":15,"prevWeekClose":13.67,"prevMonthClose":13.39,"prevQuarterClose":13.39,"fiveDayClose":13.67,"twentyDayClose":12.74,"sixtyDayClose":15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CARL\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CARL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CARL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1756526400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CARL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CARL","date":"2025-10-03","current":-2.116797,"percent":0.692308,"low":-16.302557,"twenty":-15.646752,"median":-14.592647,"eighty":-14.050912,"high":-13.042562,"avg":-14.69655,"sd":0.880134,"marketCap":354326516},"quantilePoints":[{"date":"2025-07-25","current":-15.614335,"twenty":-16.208652,"median":-15.938508,"eighty":-15.646752,"marketCap":383160159},{"date":"2025-08-01","current":-15.19291,"twenty":-15.955797,"median":-15.668364,"eighty":-15.646752,"marketCap":372818812},{"date":"2025-08-08","current":-13.129008,"twenty":-15.715909,"median":-15.64135,"eighty":-13.714681,"marketCap":322172729},{"date":"2025-08-15","current":-15.074046,"twenty":-15.668364,"median":-15.074046,"eighty":-13.919991,"marketCap":369902022},{"date":"2025-08-22","current":-13.917829,"twenty":-15.668364,"median":-14.685038,"eighty":-13.671458,"marketCap":341529609},{"date":"2025-08-29","current":-14.793096,"twenty":-15.668364,"median":-14.793096,"eighty":-13.848672,"marketCap":363007791},{"date":"2025-09-05","current":-13.711141,"twenty":-15.646752,"median":-14.674233,"eighty":-13.75266,"marketCap":343162439},{"date":"2025-09-12","current":-14.592647,"twenty":-15.566789,"median":-14.406788,"eighty":-13.75266,"marketCap":365224781},{"date":"2025-09-19","current":-16.302557,"twenty":-15.668364,"median":-14.674233,"eighty":-13.825678,"marketCap":408020406},{"date":"2025-09-26","current":-14.07224,"twenty":-15.668364,"median":-14.74447,"eighty":-13.965375,"marketCap":352200025},{"date":"2025-10-03","current":-14.157205,"twenty":-15.646752,"median":-14.592647,"eighty":-14.050912,"marketCap":354326516}],"updateTime":1759684138968},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CARL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571339747","title":"Carlsmed appoints Jennifer Kamocsay as CLO, secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2571339747","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571339747?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:20","pubTimestamp":1759152037,"startTime":"0","endTime":"0","summary":"Carlsmed (CARL) announced the appointment of Jenifer Kamocsay as Chief Legal Officer and Secretary, effective immediately. Ms. Kamocsay will serve ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/carlsmed-appoints-jennifer-kamocsay-as-clo-secretary-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/carlsmed-appoints-jennifer-kamocsay-as-clo-secretary-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","CARL"],"gpt_icon":0},{"id":"2571296336","title":"Carlsmed Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary Amid Leadership Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2571296336","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571296336?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:01","pubTimestamp":1759150881,"startTime":"0","endTime":"0","summary":"Carlsmed Inc. has appointed Jennifer Kamocsay as Chief Legal Officer and Secretary, effective immediately. Kamocsay brings over 20 years of experience in corporate legal roles at companies including Akoya Biosciences, Rubius Therapeutics, and Progress Software Corporation. She will oversee legal counsel, compliance, and corporate governance for the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire  on September 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDL5Mbxg0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRGS","BK4082","LU2095319765.USD","LU2210150020.SGD","LU2210149790.SGD","BK4121","IE00B3QW5Z07.USD","AKYA","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2065732104.USD","BK4112","BK4539","BK4097","BK4585","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","BK4588","CARL"],"gpt_icon":0},{"id":"2569551787","title":"Carlsmed Inc. Joins Russell 2000® Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2569551787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569551787?lang=en_us&edition=fundamental","pubTime":"2025-09-22 21:01","pubTimestamp":1758546060,"startTime":"0","endTime":"0","summary":"Carlsmed, Inc.  has been added to the Russell 2000 Index, effective after market close on September 22, 2025. This inclusion follows the company's successful IPO in the third quarter of 2025 and is part of the planned additions of select companies to the index.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire  on September 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nNDL2d6KMp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BKPKM429.USD","BK4082","BK4112","LU2095319765.USD","BK4588","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","BK4585","IE00BGHQF748.EUR","CARL"],"gpt_icon":0},{"id":"1167832152","title":"Goldman Sachs Highlights Two High-Potential Stocks: AI Marketing Platform Braze (BRZE.US) and Medical Technology Carlsmed (CARL.US) Receive \"Buy\" Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1167832152","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167832152?lang=en_us&edition=fundamental","pubTime":"2025-09-15 09:30","pubTimestamp":1757899840,"startTime":"0","endTime":"0","summary":"The stock market has staged a robust recovery from April's sharp decline and reached new record highs. Year-to-date, the S&P 500 has gained 11% while the Nasdaq has surged 13.5%, reflecting sustained...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683264.USD","BK4127","IE0004086264.USD","IE00BSNM7G36.USD","LU2237438978.USD","LU0048573561.USD","159891","LU0251131958.USD","LU2750360997.AUD","LU0096364046.USD","LU0742534661.SGD","LU2237443622.USD","BK4550","LU0061475181.USD","LU1868837300.USD","LU0251142724.SGD","LU2471134796.USD","BK4533","CARL","LU1668664300.SGD","BK4504","LU1868837136.USD","LU2237443465.HKD","LU0106831901.USD","LU2471134879.HKD","LU2237443549.SGD","LU1791807156.HKD","LU1868836914.USD","BK4585","IE00BFXG1179.USD","BRZE","LU2471134523.USD","BK4023","LU1804176565.USD","LU2237443895.HKD","BK4516","BK4552","IE0034235188.USD","LU2471134952.CNY","IE00B19Z3581.USD","LU1868836591.USD","LU2750360641.GBP","IE0002270589.USD","IE00B19Z3B42.SGD","BK4613","LU1894683348.USD","LU2265009873.SGD","LU2237443382.USD","LU2237443978.SGD","BK4082","LU1868836757.USD","BK4588","IE0004091025.USD"],"gpt_icon":0},{"id":"2563062878","title":"BRIEF-Carlsmed® Reports Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2563062878","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563062878?lang=en_us&edition=fundamental","pubTime":"2025-08-29 06:10","pubTimestamp":1756419058,"startTime":"0","endTime":"0","summary":"BRIEF-Carlsmed® Reports Second Quarter 2025 Financial ResultsAug 28 (Reuters) - Carlsmed Inc CARL.O:UPDATE - CARLSMED® REPORTS SECOND QUARTER 2025 FINANCIAL RESULTSSource text: ID:nGNX9kYFH0Further company coverage: CARL.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nTUA8YDMYW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CARL"],"gpt_icon":0},{"id":"2563069255","title":"Carlsmed Q2 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2563069255","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563069255?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:42","pubTimestamp":1756413727,"startTime":"0","endTime":"0","summary":"Carlsmed  reported a Q2 loss late Thursday of $1.47 per diluted share, narrower than a loss of $1.55 a year earlier.Three analysts polled by FactSet expected a loss of $0.71.Revenue for the quarter ended June 30 rose to $12.1 million from $6.1 million a year earlier.Three analysts surveyed by FactSet expected $12.0 million.The company said it expects 2025 revenue of $45.5 million to $47.5 million, representing growth of 67% to 75% over 2024. Analysts polled by FactSet expect $45.7 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CARL"],"gpt_icon":0},{"id":"2563406692","title":"Carlsmed Q2 EPS $(1.47) Misses $(1.15) Estimate, Sales $12.083M Beat $11.984M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2563406692","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563406692?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:13","pubTimestamp":1756412028,"startTime":"0","endTime":"0","summary":"Carlsmed Q2 EPS $(1.47) Misses $(1.15) Estimate, Sales $12.083M Beat $11.984M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47399799/carlsmed-q2-eps-1-47-misses-1-15-estimate-sales-12-083m-beat-11-984m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Carlsmed Q2 EPS $(1.47) Misses $(1.15) Estimate, Sales $12.083M Beat $11.984M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL"],"gpt_icon":0},{"id":"2563066550","title":"Carlsmed Inc - Reports Q2 Revenue of $12.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2563066550","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563066550?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:01","pubTimestamp":1756411260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nTUA7CKZSY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CARL","BK4082"],"gpt_icon":0},{"id":"2563066370","title":"Carlsmed Inc - Full Year Revenue Guidance $45.5M - $47.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2563066370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563066370?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:01","pubTimestamp":1756411260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nTUA7CKZSY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CARL"],"gpt_icon":0},{"id":"2563898066","title":"Press Release: Carlsmed(R) Reports Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2563898066","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563898066?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:01","pubTimestamp":1756411260,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Aug. 28, 2025  -- Carlsmed, Inc.  , a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the second quarter ended June 30, 2025.\"Our strong commercial performance was driven by the continued adoption of our highly differentiated AI-enabled aprevo technology platform and growing recognition of its ability to deliver more favorable patient outcomes than legacy devices,\" said Mike Cordonnier, Chairman and CEO of Carlsmed. \"Building upon our momentum in personalized lumbar fusion surgery, in July we successfully completed the first personalized cervical spine surgery using our aprevo technology platform, launching in 2026. We enter the second half of 2025 well positioned for continued scale as we become the new standard of care in spine fusion surgery.\". -- Revenue was $12.1 million for the second quarter of 2025; a 99% increase. compared to $6.1 million for the second quarter of 2024. This increase.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4585","BK4170","LU0203347892.USD","LU0942090050.USD","BK4082","LU0868494617.USD","NTAP","SG9999001440.SGD","LU0868494708.USD","BK4588","CARL","LU0203345920.USD","BK4022"],"gpt_icon":0},{"id":"2562210575","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2562210575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562210575?lang=en_us&edition=fundamental","pubTime":"2025-08-25 18:00","pubTimestamp":1756116000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·NAPCO Sec Tech                                  4Q       .27   7:00 AM. ·PDD Hldgs Inc.                                   2Q      2.16   6:30 AM. ·Bank of Montreal                                 3Q      2.16   5:30 AM. ·Bank of Nova Scotia                              3Q      1.26   6:00 AM. ·Box Inc. Class A                                 2Q       .31       AMC. ·Okta Inc. Class A                               2Q       .84   4:01 PM. ·BILL Hldgs Inc.                                 4Q       .41   4:05 PM. ·Greif Inc Class A                                4Q      1.39       AMC. ·J.M. Smucker Co                                  1Q      1.93   7:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GAP","HEI","LUCK","ULTA","URBN","BMO","GEF.B","PAHC","BNS","GEF","BF.B","BILL","DOMO","NSSC","MBUU","OXM","AMRK","DELL","HPQ","ATAT","AMBA","MDB","NVDA","HRL","COO","ESTC","NTAP","CMBT","HEI.A","S","AMWD","CLCO","CDLR","CARL","OOMA","HAFN","DOOO","GCO","EDAP","BF.A","FIVE","LTRX","WOLF","CM","BOX"],"gpt_icon":1},{"id":"2560763187","title":"Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage","url":"https://stock-news.laohu8.com/highlight/detail?id=2560763187","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560763187?lang=en_us&edition=fundamental","pubTime":"2025-08-19 02:25","pubTimestamp":1755541500,"startTime":"0","endTime":"0","summary":"Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/18/Medtech-Ai--Photo-via-Shutterstock.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/18/Medtech-Ai--Photo-via-Shutterstock.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/initiation/25/08/47193717/carlsmeds-personalized-spine-implants-get-significant-reimbursement-advantage","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/initiation/25/08/47193717/carlsmeds-personalized-spine-implants-get-significant-reimbursement-advantage","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4588","BK4170","LU0203347892.USD","LU0949170772.SGD","BK4585","LU2637428348.USD","LU2500361329.USD","LU0868494708.USD","LU1003077747.HKD","BK4082","CMS","LU0661504455.SGD","CAGR","CARL","BK4208","LU0553294199.USD","LU0942090050.USD","LU0545039389.USD","LU0868494617.USD","SG9999001440.SGD","LU1894683264.USD","LU2346227817.USD","LU0203345920.USD","LU0738911758.USD","NTAP","LU1894683348.USD","BK4159"],"gpt_icon":0},{"id":"2560718313","title":"Carlsmed Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2560718313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560718313?lang=en_us&edition=fundamental","pubTime":"2025-08-18 21:46","pubTimestamp":1755524761,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3UA0JE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CARL"],"gpt_icon":0},{"id":"2560902015","title":"BTIG Research Initiates Coverage on Carlsmed With Buy Rating, $21 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2560902015","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560902015?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:09","pubTimestamp":1755518975,"startTime":"0","endTime":"0","summary":"Carlsmed, Inc. (CARL) has an average rating of Buy and mean price target of $18.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CARL"],"gpt_icon":0},{"id":"2560047229","title":"Carlsmed Inc : Truist Securities Initiates Coverage With Buy Rating; Price Target $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2560047229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560047229?lang=en_us&edition=fundamental","pubTime":"2025-08-18 19:47","pubTimestamp":1755517631,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3UA057:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CARL"],"gpt_icon":0},{"id":"2560172909","title":"Carlsmed Inc : Btig Initiates Coverage With Buy Rating; Target Price $21","url":"https://stock-news.laohu8.com/highlight/detail?id=2560172909","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560172909?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:49","pubTimestamp":1755514176,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3UA0HU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CARL","BK4082"],"gpt_icon":0},{"id":"2560909931","title":"Carlsmed Initiated at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2560909931","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560909931?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:41","pubTimestamp":1755513660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CARL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 18, 2025 06:41 ET (10:41 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CARL"],"gpt_icon":0},{"id":"2560906773","title":"Truist Initiates Carlsmed at Buy With $18 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2560906773","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560906773?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:37","pubTimestamp":1755513430,"startTime":"0","endTime":"0","summary":"Truist Initiates Carlsmed at Buy With $18 Price Target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CARL"],"gpt_icon":0},{"id":"2559504459","title":"Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2559504459","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559504459?lang=en_us&edition=fundamental","pubTime":"2025-08-14 21:05","pubTimestamp":1755176700,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Aug.  14, 2025  (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/14/3133554/0/en/Carlsmed-Inc-to-Report-Second-Quarter-2025-Financial-Results-on-August-28-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CARL"],"gpt_icon":0},{"id":"2556819636","title":"Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures","url":"https://stock-news.laohu8.com/highlight/detail?id=2556819636","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556819636?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:05","pubTimestamp":1754053500,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Aug.  01, 2025  (GLOBE NEWSWIRE) -- Carlsmed, Inc. (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/01/3125819/0/en/Carlsmed-s-aprevo-Personalized-Interbody-Implants-Receive-CMS-New-Technology-Add-On-Payment-NTAP-for-Cervical-Fusion-Procedures.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494708.USD","LU0738911758.USD","LU2637428348.USD","LU0553294199.USD","LU0661504455.SGD","LU1003077747.HKD","LU0203347892.USD","LU0942090050.USD","LU0203345920.USD","CARL","LU0949170772.SGD","BK4208","BK4585","LU1894683348.USD","BK4170","CMS","LU0545039389.USD","LU2346227817.USD","LU0868494617.USD","BK4588","NTAP","SG9999001440.SGD","LU1894683264.USD","LU2500361329.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}]}}